Boosting Natural Killer Cell Therapies in Glioblastoma Multiforme Using Supramolecular Cationic Inhibitors of Heat Shock Protein 90

Allogeneic natural killer (aNK) cell adoptive therapy has the potential to dramatically impact clinical outcomes of glioblastoma multiforme (GBM). However, in order to exert therapeutic activity, NK cells require tumor expression of ligands for activating receptors, such as MHC Class I peptide A/B (...

Descrición completa

Detalles Bibliográficos

Principais autores:	Tanmoy Saha, Amanda A. van Vliet, Chunxiao Cui, Jorge Jimenez Macias, Arpita Kulkarni, Luu Nhat Pham, Sean Lawler, Jan Spanholtz, Anna-Maria Georgoudaki, Adil Doganay Duru, Aaron Goldman
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2021-12-01
Series:	Frontiers in Molecular Biosciences
Assuntos:	cell therapy glioblastoma multiforme nanotechnology natural killer cells (NK cells) allogeneic natural killer cells
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fmolb.2021.754443/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!